MENINGITIS: Inflammation of the Meninges
Meningitis is an acute inflammatory condition affecting the meninges, the protective membranes surrounding the brain and spinal cord. It is most commonly caused by infectious pathogens, particularly bacteria and viruses, and can progress rapidly to severe neurological injury or death if not recognised and treated early. The clinical urgency of meningitis arises from the confined intracranial space in which inflammation occurs, where even modest increases in volume can have profound physiological consequences.
The pathophysiology of meningitis explains both its classic presenting features and its potential for sudden deterioration. Inflammation within the subarachnoid space disrupts cerebrospinal fluid dynamics, increases intracranial pressure and compromises cerebral perfusion, placing highly metabolically active neurons at significant risk of secondary injury.
What You Need to Know
Meningitis is an inflammatory condition of the meninges that occurs when pathogens gain access to the subarachnoid space and provoke a strong immune response. Once microorganisms enter the cerebrospinal fluid, inflammatory mediators increase blood–brain barrier permeability, meaning the normally selective barrier between the bloodstream and brain tissue becomes leaky. Immune cells, plasma proteins, and fluid move into the CSF, producing an inflammatory exudate that disrupts normal CSF circulation and absorption.
As inflammation progresses, intracranial volume rises due to a combination of cerebral oedema, increased CSF volume, and vascular congestion. This rise in intracranial pressure is a central driver of neurological deterioration in meningitis. Because the skull is a fixed space, even modest increases in volume can significantly raise pressure, compress brain tissue, and impair normal neuronal function.
Several interrelated processes contribute to early physiological deterioration:
Increased blood–brain barrier permeability allowing inflammatory fluid and cells into the CSF
Impaired CSF flow and absorption, leading to accumulation of intracranial volume
Rising intracranial pressure that compromises cerebral perfusion
As intracranial pressure rises, cerebral perfusion pressure falls, reducing delivery of oxygen and glucose to brain tissue. Neurons are highly sensitive to reductions in energy supply, so dysfunction can occur rapidly, even before structural injury is visible on imaging. This explains why patients may deteriorate quickly and why early recognition of physiological changes is critical, rather than relying solely on radiological findings to assess severity.
Beyond the Basics
Entry of pathogens and initiation of inflammation
Pathogens responsible for meningitis most commonly reach the central nervous system via haematogenous spread, meaning they travel through the bloodstream, often originating from the nasopharynx or another systemic site. Once organisms cross the blood–brain barrier and enter the subarachnoid space, they encounter relatively limited local immune defences. This allows rapid replication within the cerebrospinal fluid, where normal immune surveillance is minimal.
Recognition of pathogens by resident immune cells triggers release of cytokines and other inflammatory mediators, which are signalling molecules that coordinate immune responses. While this inflammatory reaction is necessary to control infection, it also disrupts the tightly regulated intracranial environment. Increased vascular permeability and immune cell recruitment contribute to tissue injury and set the stage for raised intracranial pressure.
Blood–brain barrier disruption and CSF changes
Inflammatory mediators act on endothelial cells lining cerebral blood vessels, causing loosening of tight junctions within the blood–brain barrier, the structure that normally restricts movement of substances into the brain. As a result, plasma proteins and leukocytes enter the cerebrospinal fluid, altering its normal composition.
CSF protein levels rise and cellular debris accumulates, increasing fluid viscosity and impairing normal CSF circulation. Absorption of CSF at the arachnoid granulations, which are specialised structures responsible for CSF drainage, becomes reduced. This leads to accumulation of CSF within the cranial vault and further elevation of intracranial pressure. These processes occur rapidly in bacterial meningitis, explaining its typically more severe and fulminant clinical course compared with viral meningitis.
Cerebral oedema and raised intracranial pressure
Cerebral oedema is a major contributor to raised intracranial pressure in meningitis and occurs through multiple mechanisms. Cytotoxic oedema results from direct neuronal and glial cell injury, causing intracellular swelling as cells lose the ability to regulate water and ion movement. Vasogenic oedema develops when plasma fluid leaks into the interstitial space due to breakdown of the blood–brain barrier.
As oedema progresses, intracranial compliance, meaning the brain’s ability to accommodate volume changes, decreases. Once compensatory mechanisms such as CSF displacement and venous compression are exhausted, even small increases in volume produce large rises in intracranial pressure. This explains the often rapid neurological deterioration seen in severe meningitis.
Impaired cerebral perfusion and secondary ischaemia
Rising intracranial pressure reduces cerebral perfusion pressure, which is the pressure gradient driving blood flow to brain tissue. As perfusion falls, delivery of oxygen and glucose becomes inadequate, particularly in vulnerable regions of the brain.
Neurons are highly metabolically active and rely on continuous energy supply to maintain membrane potentials. When oxygen and glucose delivery is compromised, neurons rapidly lose electrical stability, leading to dysfunction and, if prolonged, irreversible injury. This secondary ischaemic damage explains why neurological deterioration may continue despite appropriate antimicrobial therapy if intracranial pressure is not recognised and managed early.
Neuronal excitability and seizure risk
Inflammation, metabolic stress, and disrupted ionic homeostasis increase neuronal excitability, meaning neurons are more likely to fire abnormally. Changes in sodium, potassium, and calcium gradients, combined with cortical irritation from inflammation, lower the seizure threshold.
Seizures in meningitis therefore reflect both cortical involvement and physiological instability. They often indicate severe disease, rising intracranial pressure, or evolving cerebral injury, and are associated with poorer neurological outcomes when they occur early or are difficult to control.
Clinical Connections
Meningitis is a neurological emergency in which early clinical assessment strongly influences survival and long-term neurological outcome. Deterioration often begins with subtle changes rather than dramatic signs. Worsening headache, increasing photophobia, altered behaviour, or mild reductions in consciousness may precede rapid neurological decline. These early features reflect rising intracranial pressure and evolving cerebral dysfunction rather than established structural injury.
Rising intracranial pressure may initially present with restlessness, nausea, or vomiting as compensatory mechanisms are exhausted. As pressure continues to increase, cerebral perfusion falls and brainstem function may become compromised, leading to reduced responsiveness, pupillary changes, or abnormal posturing. Neck stiffness represents meningeal irritation caused by inflammation within the subarachnoid space rather than musculoskeletal pathology, and when combined with fever or altered mental state it signals significant intracranial pathology requiring urgent escalation.
Several clinical changes are particularly concerning because they suggest worsening intracranial physiology:
Sudden seizure activity indicating cortical irritation or rising intracranial pressure
Acute drops in level of consciousness reflecting impaired cerebral perfusion
Changes in heart rate, blood pressure, or respiratory pattern suggesting brainstem involvement
Importantly, neurological deterioration may occur even after antimicrobial therapy has been commenced. Progression at this stage does not imply treatment failure but reflects ongoing inflammatory injury, cerebral oedema, or impaired perfusion. Interpreting clinical changes through the lens of intracranial physiology allows earlier recognition of secondary deterioration and supports timely intervention in a condition where progression can be rapid and unpredictable.
Concept Check
Why does inflammation of the meninges increase intracranial pressure?
How does blood–brain barrier disruption alter CSF dynamics in meningitis?
Why is bacterial meningitis associated with more severe neurological compromise than viral meningitis?
How does raised intracranial pressure reduce cerebral perfusion?
Why are seizures a concerning feature in meningitis?